A Rapid, Sensitive Assay to Detect EGFR Mutation in Small Biopsy Specimens from Lung Cancer

This publication has 26 references indexed in Scilit:

• Oncogenic Transformation by Inhibitor-Sensitive and -Resistant EGFR Mutants
  PLoS Medicine, 2005
• Epidermal Growth Factor–Independent Transformation of Ba/F3 Cells with Cancer-Derived Epidermal Growth Factor Receptor Mutants Induces Gefitinib-Sensitive Cell Cycle Progression
  Cancer Research, 2005
• EGFR Mutation Status in Japanese Lung Cancer Patients: Genotyping Analysis Using LightCycler
  Clinical Cancer Research, 2005
• Acquired Resistance of Lung Adenocarcinomas to Gefitinib or Erlotinib Is Associated with a Second Mutation in the EGFR Kinase Domain
  PLoS Medicine, 2005
• Gefitinib Induces Apoptosis in the EGFRL858R Non–Small-Cell Lung Cancer Cell Line H3255
  Cancer Research, 2004
• EGF receptor gene mutations are common in lung cancers from “never smokers” and are associated with sensitivity of tumors to gefitinib and erlotinib
  Proceedings of the National Academy of Sciences, 2004
• EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy
  Science, 2004
• Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to Gefitinib
  New England Journal of Medicine, 2004
• Overview of epidermal growth factor receptor biology and its role as a therapeutic target in human neoplasia
  Seminars in Oncology, 2002
• Addiction to Oncogenes--the Achilles Heal of Cancer
  Science, 2002